Noncoding RNAs in asthmatic airway smooth muscle cells

Area of Science:

• Pulmonology
• Molecular Biology
• Genetics

Background:

• Asthma involves complex genetic, environmental, and epigenetic factors.
• Irreversible pathological changes in airway smooth muscle cells (ASMCs), like hyperplasia and hypertrophy, occur in asthma.
• Identifying mechanisms driving ASMC pathology is crucial for asthma management.

Purpose of the Study:

• To review recent research on noncoding RNAs (ncRNAs) in airway smooth muscle cell (ASMC) pathologies.
• To highlight the association between ncRNAs and ASMC abnormalities in asthma.
• To provide a resource for future research on ncRNAs in asthma diagnostics and therapeutics.

Main Methods:

• Literature review of recent studies on ncRNAs and ASMC pathologies in asthma.
• Focus on microRNAs, long noncoding RNAs, and circular RNAs.
• Development of a schematic illustrating ncRNA roles in ASMC pathophysiology.

Main Results:

• Noncoding RNAs (ncRNAs) are increasingly recognized as key players in asthma-related ASMC abnormalities.
• Specific types of ncRNAs, including microRNAs, long noncoding RNAs, and circular RNAs, are implicated.
• Research indicates a significant association between ncRNAs and pathological changes in ASMCs.

Conclusions:

• Noncoding RNAs (ncRNAs) play a critical role in the pathophysiology of airway smooth muscle cells (ASMCs) in asthma.
• Further investigation into ncRNA mechanisms can lead to novel diagnostic and therapeutic strategies for asthma.
• The presented schematic can guide future research endeavors in asthma treatment and diagnosis.